Sonic Healthcare stock holds at AUD 18.72 as FY2026 growth sets the test

Published on 10/07/2026 at 02:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonic Healthcare stock reported AUD 10.867 billion in FY2026 revenue and AUD 621 million in underlying net profit. FY2027 EBITDA guidance reaches AUD 2.03 billion.

Sonic, AU000000SHL7, Illustration mit AI erstellt.

Sonic Healthcare stock was last at AUD 18.72 on the ASX on October 7, 2026, with the session change at 0 percent. The company enters the new fiscal year after reporting FY2026 revenue of AUD 10.867 billion, up 13 percent year over year, according to Yahoo Finance.

Revenue growth sets the baseline

The FY2026 result combined revenue of AUD 10.867 billion with underlying EBITDA of AUD 1.933 billion, an 11 percent increase from FY2025. Underlying net profit rose 17 percent to AUD 621 million, while earnings per share increased 14 percent to AUD 1.26.

Sonic Healthcare identifies the FY2026 annual report as the source of revenue of AUD 10.9 billion, underlying EBITDA of AUD 1.93 billion and underlying net profit of AUD 621 million. The detailed figures from the earnings presentation show that profit growth outpaced revenue growth by 4 percentage points.

FY2027 guidance meets pressure

Management guided to constant-currency FY2027 EBITDA of AUD 1.95 billion to AUD 2.03 billion. The range compares with FY2026 EBITDA of AUD 1.933 billion and leaves execution in the United States, Switzerland and the United Kingdom central to the earnings outlook.

The earnings call also identified AUD 25 million to AUD 30 million of expected FY2027 earnings support from U.S. operating improvements. At the same time, Swiss regulatory changes are expected to reduce FY2027 revenue by CHF 20 million, while the U.K. Hertfordshire and West Essex contract is taking longer to reach planned margins, according to Yahoo Finance.

Consensus remains at Hold

Ord Minnett maintained a Hold rating and set a price target of AUD 19.90, while the published consensus was also Hold with an average target of AUD 22.27, according to Markets Insider. The average target stands 18.96 percent above the AUD 18.72 ASX price, while Ord Minnett's target is 6.30 percent higher.

For investors, the key tension is visible in the numbers: FY2026 revenue and profit accelerated, but FY2027 guidance incorporates Swiss fee pressure and delayed U.K. contract benefits. The U.S. efficiency program is therefore a measurable offset rather than a separate growth story.

Stock stays below yearly high

Sonic Healthcare was last at AUD 18.72 on the ASX on October 7, 2026, with a 52-week range of AUD 18.26 to AUD 24.27 and market capitalization of AUD 9.3 billion. Volume stood at 1,154,030 shares, giving the stock a concrete valuation marker as the FY2027 execution cycle begins.